Autolus Advances New Myeloma CAR T-cell Therapy in Clinical Trial – Myeloma Research News
Myeloma Research News |
Autolus Advances New Myeloma CAR T-cell Therapy in Clinical Trial
Myeloma Research News Autolus has successfully completed dosing the first group of patients in a Phase 1/2 trial of AUTO2 — a CAR T-cell therapy that targets two factors that drive disease in patients with relapsed or refractory multiple myeloma. Researchers believe that … |
